S-1/A: Lifeward Ltd. Files Amendment for Resale of 1.9 Million Shares Issuable Upon Warrant Exercise
S-1/A Filing
Lifeward Ltd. is filing an amendment to its registration statement for the resale of up to 1.9 million ordinary shares issuable upon the exercise of outstanding warrants.
Summary
- Lifeward Ltd. has filed an amendment to its registration statement to allow selling shareholders to resell up to 1,927,274 ordinary shares.
- These shares are issuable upon the exercise of outstanding warrants from a January 2025 private placement.
- The warrants include those issued to institutional investors and designees of H.C. Wainwright & Co., LLC.
- Lifeward will not receive any proceeds from the resale of these shares by the selling shareholders.
- However, Lifeward could receive up to $5.4 million if the warrants are exercised for cash.
- The selling shareholders may sell the shares at varying prices and through different methods.
- The company's ordinary shares are traded on the Nasdaq Capital Market under the symbol LFWD, with the last reported sales price on February 12, 2025, being $1.97 per share.
- Investing in Lifeward's ordinary shares involves a high degree of risk.
Sentiment
Score: 5
Explanation: Neutral sentiment. The document primarily focuses on the mechanics of a share resale registration, with standard risk disclosures.
Positives
- The company could receive up to $5.4 million if the warrants are exercised for cash.
- The company is enabling the resale of 1,927,274 ordinary shares issuable upon warrant exercise.
Negatives
- Lifeward will not receive any proceeds from the sale of Ordinary Shares by the selling shareholders.
- Investing in Lifeward's ordinary shares involves a high degree of risk.
Risks
- Investing in our ordinary shares involves a high degree of risk.
- The selling shareholders may offer and sell the Ordinary Shares from time to time at varying prices and in a number of different ways as each selling shareholder may determine through public or private transactions or through other means described under Plan of Distribution.
Future Outlook
The selling shareholders may offer and sell the Ordinary Shares from time to time at varying prices and in a number of different ways as each selling shareholder may determine through public or private transactions or through other means described under Plan of Distribution.
Industry Context
This announcement is typical for companies that have recently completed a private placement and are registering the shares for resale to provide liquidity to investors.
Stakeholder Impact
- Potential dilution for existing shareholders if warrants are exercised.
- Increased liquidity for warrant holders.
Next Steps
- The selling shareholders may offer and sell the Ordinary Shares from time to time at varying prices and in a number of different ways as each selling shareholder may determine through public or private transactions or through other means described under Plan of Distribution.
Key Dates
| Date | Description |
|---|---|
| 2015-12-31 | Warrants granted to Kreos Capital V (Expert Fund) Limited |
| 2016-12-28 | Common warrants issued as part of loan agreement drawdown |
| 2019-02-25 | Warrants issued to placement agent for follow-on public offering |
| 2019-04-05 | Warrants issued to institutional purchasers in registered direct offering |
| 2019-06-05 | Warrants issued to institutional investors in warrant exercise agreement |
| 2019-06-10 | Warrants issued to placement agent for warrant exercise agreement |
| 2019-06-12 | Warrants issued to certain institutional investors in warrant exercise agreement |
| 2020-02-10 | Warrants issued to institutional purchasers in private placement |
| 2020-07-06 | Warrants issued to institutional purchasers in registered direct offering |
| 2020-12-08 | Warrants issued to institutional purchasers in private placement |
| 2021-02-26 | Warrants issued to institutional purchasers in private placement |
| 2021-09-27 | Warrants issued to institutional purchasers in registered direct offering |
| 2024-03-15 | Effective date of one-for-seven reverse share split |
| 2025-01-07 | Date of securities purchase agreement for January 2025 Private Placement |
| 2025-02-12 | Last reported sales price of Ordinary Shares on Nasdaq Capital Market ($1.97) |
| 2025-12-30 | Expiration date of Kreos Capital warrants (if not earlier) |
Keywords
warrants, ordinary shares, resale, private placement, Lifeward, LFWD, exercise
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.